• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print

Corporate Spotlight

Race Oncology Ltd (RAC) is a specialty pharmaceutical company. Its business model is to pursue later stage drug assets, principally in the cancer field. Its important asset is a chemotherapy drug, called Bisantrene. Race Oncology is rediscovering Bisantrene.
View the full Corporate Spotlight arrow Created with Sketch.

director sees
refresh Created with Sketch. REFRESH
Last update - 16.20pm 18/01/2019 (20 minute delay) ?
Day
Open 9.9¢   Day High 10.0¢   Day Low 9.9¢
Daily Volume 44000
Bids   Sellers
Number Price Volume   Number Price Volume
1 9.1¢ 52381   1 9.9¢ 39031

Directors & Senior Management

Mr. Peter Molloy Chief Executive Officer
Dr. William J. Garner Chairman of the Board
Mr. Peter Molloy Chief Executive Officer
Dr. Samar Al-Behaisi Chief Medical Officer and Vice President - Medical Affairs
Mr. Peter Gordon Webse Company Secretary
Mr. Chris Ntoumenopoulos Director
Mr. John Cullity Non-Executive Director

Data source: Thomson Reuters [email protected]

GET SUPPORT arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.